COVID-19–related skin manifestations: Update on therapy

Cucinotta, 2020, WHO declares COVID-19 a pandemic, Acta Biomed, 91, 157 Recalcati, 2020, Cutaneous manifestations in COVID-19: a first perspective, J Eur Acad Dermatol Venereol, 34 Marzano, 2020, Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients, J Am Acad Dermatol, 83, 280, 10.1016/j.jaad.2020.04.044 Galván Casas, 2020, Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases, Br J Dermatol, 183, 71, 10.1111/bjd.19163 Fernandez-Nieto, 2020, Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak, J Am Acad Dermatol, 83 De Giorgi, 2020, Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): a prospective study from China and Italy, J Am Acad Dermatol, 83, 674, 10.1016/j.jaad.2020.05.073 Su, 2020, Viral exanthem in COVID-19, a clinical enigma with biological significance, J Eur Acad Dermatol Venereol, 15 Tammaro, 2020, Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome, J Eur Acad Dermatol Venereol, 24 Mungmungpuntipantip, 2020, COVID-19 and cutaneous manifestations, J Eur Acad Dermatol Venereol, 34, e246 Guarneri, 2020, Diversity of clinical appearance of cutaneous manifestations in the course of COVID-19, J Eur Acad Dermatol Venereol, 34, 10.1111/jdv.16669 Recalcati, 2020, Chilblain-like lesions during the COVID-19 pandemic: early or late sign?, Int J Dermatol, 59, 10.1111/ijd.14975 Wollina, 2020, Cutaneous signs in COVID-19 patients: a review, Dermatol Ther, 33, e13549, 10.1111/dth.13549 Gisondi, 2020, Cutaneous manifestations of SARS-CoV-2 infection: a clinical update, J Eur Acad Dermatol Venereol, 34, 2499, 10.1111/jdv.16774 Singh H, Kaur H, Singh K, Sen CK. Cutaneous manifestations of COVID-19: a systematic review. Adv Wound Care, in press. Freeman, 2020, The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries, J Am Acad Dermatol, 83, 1118, 10.1016/j.jaad.2020.06.1016 Feldman SR, Freeman EE. Coronavirus disease 2019 (COVID-19): cutaneous manifestations and issues related to dermatologic care. Available at: https://www.uptodate.com/contents/coronavirusdisease-2019-covid-19-cutaneousmanifestations-and-issues-related-todermatologic-care, Last Accessed Sep 28, 2020. Almutairi, 2020, COVID-19 with dermatologic manifestations and implications: an unfolding conundrum, Dermatol Ther, 33, e13544, 10.1111/dth.13544 Docampo-Simón, 2020, Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review, J Eur Acad Dermatol Venereol, 34, 10.1111/jdv.16665 Matar, 2020, Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature, J Eur Acad Dermatol Venereol, 34, 10.1111/jdv.16775 Riphagen, 2020, Hyperinflammatory shock in children during COVID-19 pandemic, Lancet, 395, 1607, 10.1016/S0140-6736(20)31094-1 Bapst, 2020, Special dermatological presentation of paediatric multisystem inflammatory syndrome related to COVID-19: erythema multiforme, BMJ Case Rep, 13, 10.1136/bcr-2020-236986 Verdoni, 2020, An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study, Lancet, 395, 1771, 10.1016/S0140-6736(20)31103-X Kaya, 2020, Clinical and histopathological features and potential pathological mechanisms of skin lesions in COVID-19: review of the literature, Dermatopathology (Basel), 7, 3, 10.3390/dermatopathology7010002 Torrelo, 2020, Erythema multiforme-like lesions in children and COVID-19, Pediatr Dermatol, 37, 442, 10.1111/pde.14246 Roca-Ginés, 2020, Assessment of acute acral lesions in a case series of children and adolescents during the COVID-19 pandemic, JAMA Dermatol, 156, 992, 10.1001/jamadermatol.2020.2340 Caselli, 2020, No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain, Br J Dermatol, 183, 784, 10.1111/bjd.19349 Kolivras, 2020, Coronavirus (COVID-19) infection-induced chilblains: a case report with histopathologic findings, JAAD Case Rep, 6, 489, 10.1016/j.jdcr.2020.04.011 El Hachem, 2020, A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection, J Eur Acad Dermatol Venereol, 34, 2620, 10.1111/jdv.16682 Colmenero, 2020, SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases, Br J Dermatol, 183, 729, 10.1111/bjd.19327 Magro, 2020, Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases, Transl Res, 220, 1, 10.1016/j.trsl.2020.04.007 Zhang, 2020, Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients, J Thromb Thrombolysis, 50, 580, 10.1007/s11239-020-02182-9 Fernandez-Nieto, 2020, Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital, Clin Exp Dermatol, 45, 872, 10.1111/ced.14277 Llamas-Velasco, 2020, Comment on ‘clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital’. Pseudoherpetic Grover disease seems to appear in patients with COVID-19 infection, Clin Exp Dermatol, 45, 896, 10.1111/ced.14305 Mahé, 2020, Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not ‘varicella-like.’, J Eur Acad Dermatol Venereol, 34, 10.1111/jdv.16706 Pavone P, Marino S, Marino L, et al. Chilblains-like lesions and SARS-CoV-2 in children: an overview in therapeutic approach. Dermatol Ther, in press. Gallizzi R, Sutera D, Spagnolo A, et al. Management of pernio-like cutaneous manifestations in children during the outbreak of COVID-19. Dermatol Ther, in press. Piccolo, 2020, Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients, J Eur Acad Dermatol Venereol, 34, e291, 10.1111/jdv.16526 Colonna, 2020, Chilblain-like lesions in children following suspected COVID-19 infection, Pediatr Dermatol, 37, 437, 10.1111/pde.14210 Recalcati, 2020, Acral cutaneous lesions in the time of COVID-19, J Eur Acad Dermatol Venereol, 34, 10.1111/jdv.16533 Romaní, 2020, Chilblain and Acral Purpuric Lesions in Spain during Covid Confinement: Retrospective Analysis of 12 Cases, Actas Dermosifiliogr, 111, 426, 10.1016/j.ad.2020.04.002 Ludzik, 2020, Case report: chilblains-like lesions (COVID-19 toes) during the pandemic-is there a diagnostic window?, F1000 Res, 9, 668 Mohan, 2020, Chilblains in COVID-19 infection, Cureus, 12, e9245 Ladha, 2020, Approach to chilblains during the COVID-19 pandemic [formula: see text], J Cutan Med Surg, 24, 504, 10.1177/1203475420937978 Saenz Aguirre, 2020, Novel outbreak of acral lesions in times of COVID-19: a description of 74 cases from a tertiary university hospital in Spain, Clin Exp Dermatol, 45, 1065, 10.1111/ced.14294 Kakodkar, 2020, A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19), Cureus, 12, e7560 Ehsani, 2020, Pityriasis rosea as a cutaneous manifestation of COVID-19 infection, J Eur Acad Dermatol Venereol, 34, 10.1111/jdv.16579 Mahé, 2020, A distinctive skin rash associated with coronavirus disease 2019?, J Eur Acad Dermatol Venereol, 34, 10.1111/jdv.16471 Gianotti, 2020, Cutaneous clinico-pathological findings in three COVID-19-positive patients observed in the metropolitan area of Milan, Italy, Acta Derm Venereol, 100, 10.2340/00015555-3490 Iancu, 2020, Viral exanthema as manifestation of SARS-CoV-2 infection: a case report, Medicine, 99, e21810, 10.1097/MD.0000000000021810 Abuelgasim E, Dona ACM, Sondh RS, Harky A. Management of urticaria in COVID-19 patients: a systematic review. Dermatol Ther.2020, in press. Henry, 2020, Urticarial eruption in COVID-19 infection, J Eur Acad Dermatol Venereol, 34, 10.1111/jdv.16472 Van Damme, 2020, Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection, J Eur Acad Dermatol Venereol, 34, 10.1111/jdv.16523 Quintana-Castanedo, 2020, Urticarial exanthem as early diagnostic clue for COVID-19 infection, JAAD Case Rep, 6, 498, 10.1016/j.jdcr.2020.04.026 Shansai M. Low-dose systemic steroids, an emerging therapeutic option for COVID-19 related urticaria. J Dermatol Treat,2020, in press. Shanshal M. COVID-19 related anagen effluvium. J Dermatolog Treat,in press. Zhou, 2020, Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report, J Thromb Thrombolysis, 50, 229, 10.1007/s11239-020-02084-w Manalo, 2020, A dermatologic manifestation of COVID-19: transient livedo reticularis, J Am Acad Dermatol, 83, 700, 10.1016/j.jaad.2020.04.018 Jimenez-Cauhe, 2020, Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings, Clin Exp Dermatol, 45, 892, 10.1111/ced.14281 Demirbaş A, Elmas OF, Atasoy M, Türsen U, Lotti T. A case of erythema multiforme major in a patient with COVID 19: the role of corticosteroid treatment. Dermatol Ther, in press. Mayor-Ibarguren, 2020, Cutaneous small vessel vasculitis secondary to COVID-19 infection: a case report, J Eur Acad Dermatol Venereol, 34, 10.1111/jdv.16670 Camprodon Gómez, 2020, Leucocytoclastic vasculitis in a patient with COVID-19 with positive SARS-CoV-2 PCR in skin biopsy, BMJ Case Rep, 13, 10.1136/bcr-2020-238039 Caputo, 2020, A generalized purpuric eruption with histopathologic features of leucocytoclastic vasculitis in a patient severely ill with COVID-19, J Eur Acad Dermatol Venereol, 34, 10.1111/jdv.16737 Freeman, 2020, Creating dermatology guidelines for COVID-19: the pitfalls of applying evidence-based medicine to an emerging infectious disease, J Am Acad Dermatol, 82, 10.1016/j.jaad.2020.04.002 Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with COVID-19 - preliminary report. N Engl J Med, in press. Prescott, 2020, Corticosteroids in COVID-19 ARDS: evidence and hope during the pandemic, JAMA, 324, 1292, 10.1001/jama.2020.16747 Atzori, 2020, Cutaneous drug eruptions associated with COVID-19 therapy, JAAD Int, 1, 73, 10.1016/j.jdin.2020.05.004